Allogene Therapeutics, Inc.

ALLONASDAQHealthcare● Active

$1.84

$-0.05(-2.39%)

Market Cap$447500340

P/E Ratio—

52W High$4.46

52W Low$0.98

Avg Volume9.8M

Open$1.91

Beta0.46

Employees Ownership Insider Trades

Allogene Therapeutics, Inc. (ALLO) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ALLO · as of Mar 12, 2026

Latest filing snapshot

152

-74-32.74%vs prior year

Allogene Therapeutics, Inc. (ALLO) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

152

Change (1Y)

-74

Growth % (1Y)

-32.74%

Revenue / Employee

—

Net Income / Employee

$-1.26M

Market Cap

$442M

ALLO Employee Count

2018 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-12	2025-12-31	152	-74	-32.74%
2025-03-13	2024-12-31	226	-7	-3.00%
2024-03-14	2023-12-31	233	-128	-35.46%
2023-02-28	2022-12-31	361	+51	+16.45%
2022-02-23	2021-12-31	310	+45	+16.98%
2021-02-25	2020-12-31	265	+59	+28.64%
2020-02-27	2019-12-31	206	+84	+68.85%
2019-03-08	2018-12-31	122	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

EDIT

Editas Medicine, Inc.

Allogene Therapeutics, Inc.YOU

152$442M #5

CRBU

Caribou Biosciences, Inc.

147$184M #6

AVIR

Atea Pharmaceuticals, Inc.

56$348M #7

ACHV

Achieve Life Sciences, Inc.

25$549M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ALLO peer comparison

About ALLO employees

ALLO Employees · Headcount

Allogene Therapeutics, Inc. (ALLO) employee data is sourced from the annual SEC 10-K filing. As of 2025, Allogene Therapeutics, Inc. had 152 full-time employees globally. Full-time employees only. Global consolidated headcount.

Allogene Therapeutics, Inc.'s workforce decreased by 74 (32.74%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

ALLO Employees · 5 questions

As of the latest SEC 10-K filing (2025), Allogene Therapeutics, Inc. had 152 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Allogene Therapeutics, Inc. employee counthow many employees does Allogene Therapeutics, Inc. haveALLO total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-12